TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Xtant Medical Holdings ( (XTNT) ) has provided an announcement.
Xtant Medical Holdings, Inc. has scheduled its 2025 Annual Meeting of Stockholders for November 7, 2025, with details to be provided in the company’s proxy statement. The change in the meeting date requires stockholders to submit proposals by August 18, 2025, to be considered for inclusion in the proxy materials, following SEC rules and the company’s bylaws.
The most recent analyst rating on (XTNT) stock is a Buy with a $1.50 price target. To see the full list of analyst forecasts on Xtant Medical Holdings stock, see the XTNT Stock Forecast page.
Spark’s Take on XTNT Stock
According to Spark, TipRanks’ AI Analyst, XTNT is a Neutral.
Xtant Medical Holdings shows strong revenue growth and strategic progress, such as new product launches and board restructuring. However, significant challenges remain, including financial instability due to persistent negative profitability and cash flows, as well as bearish technical signals. The valuation is also a concern, with a negative P/E ratio. These risks weigh heavily, resulting in a lower overall score.
To see Spark’s full report on XTNT stock, click here.
More about Xtant Medical Holdings
Average Trading Volume: 183,877
Technical Sentiment Signal: Strong Sell
Current Market Cap: $79.72M
For detailed information about XTNT stock, go to TipRanks’ Stock Analysis page.